The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

NCT02457689 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: GTU®-MultiHIV B Clade Vaccine
OTHER: Sodium chloride BP

Sponsor

Imperial College London

Collaborators

[object Object]